FDA Takes Asthma Medication off the Market

The Obama Adminstration moves in its war against affordable Medical care to eliminate Primatine Mist.

The only over-the-counter asthma inhaler sold in the United States will no longer be available next year as part of an international agreement to stop the use of substances that damage the environment.

Primatene Mist (epinephrine) is approved by the Food and Drug Administration (FDA) for the temporary relief of occasional symptoms of mild asthma. FDA urges those who use Primatene Mist to see a health care professional soon to switch to another asthma medicine.

Primatene Mist inhalers are being discontinued because they use chlorofluorocarbons (CFCs) as a propellant (spray) to move the medicine out of the inhaler so patients can breathe the medicine into their lungs.

CFCs harm the environment by decreasing the earth’s ozone layer. This layer of the atmosphere protects us from some of the sun’s harmful ultraviolet radiation, which can increase the risk of skin cancers and cataracts. The United States and most other countries have signed an international agreement to phase out CFCs and other ozone-depleting substances.

Asthmatics will be forced to use prescription medications that are more expencive and may not even work as well all in the name of  political correctness.

 

One thought on “FDA Takes Asthma Medication off the Market”

Leave a Reply